Inequalities in cancer outcomes
This Cancer Research UK funded Programme has as its main ambition to reduce inequalities in cancer survival, ensuring that everyone, regardless of sociodemographic background, benefits from improvements in cancer care.
This four-year ERC Horizon 2020 funded project (2020-2023), involves 13 institutions from 9 different countries and is led by the Hospices Civils de Lyon, France. It aims to develop a platform to collect, manage and analyse a large amount of data…
Policy Research Unit in Cancer Awareness
Since 2011, we have been part of the twice awarded Policy Research Unit in Cancer Awareness, Screening and Early Diagnosis funded by the NIHR Policy Research Programme.
- This study aimed to evaluate the association between thyroid dysfunction and breast cancer risk. We included 239,436 females of the UK Biobank cohort. Information on thyroid dysfunction, personal and family […]
- Correction to: Probabilities of ICU admission and hospital discharge according to patient characteristics in the designated COVID-19 hospital of Kuwait.It was highlighted that in the original article, the Additional file 1 was missing. This Correction article includes the Additional file 1. The original article has been updated.
- Examining the role of comorbidity in socio-economic inequalities in short-term mortality among colon cancer patients in EnglandColon cancer is one of the most common cancers diagnosed in England. Despite the universal healthcare system, the most deprived groups of colon cancer patients have a poorer prognosis than […]
- Can we screen for pancreatic cancer? Identifying a sub-population of patients at high risk of subsequent diagnosis using machine learning techniques applied to primary care data.BACKGROUND: Pancreatic cancer (PC) represents a substantial public health burden. Pancreatic cancer patients have very low survival due to the difficulty of identifying cancers early when the tumour is localised […]
- Economic impact of avoidable cancer deaths caused by diagnostic delay during the COVID-19 pandemic: A national population-based modelling study in England, UK.INTRODUCTION: Delays in cancer diagnosis arose from the commencement of non-pharmaceutical interventions (NPI) introduced in the UK in March 2020 in response to the COVID-19 pandemic. Our earlier work predicted […]